Bertolino Arthur Peter 4
4 · Innovation Pharmaceuticals Inc. · Filed Sep 24, 2018
Insider Transaction Report
Form 4
Bertolino Arthur Peter
Pres. & Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-09-01+617,839→ 617,839 totalExercise: $0.40Exp: 2028-09-01→ Class A Common Stock (617,839 underlying) - Award
Class A Common Stock
2018-09-01+1,066,667→ 2,699,873 total
Footnotes (1)
- [F1]The restricted stock and stock options vest upon the earliest of (i) 50% on September 1, 2019 and 50% on September 1, 2020; (ii) the Company's common stock closes above $3.00 per share (as may be adjusted for any stock splits or similar actions); (iii) the commencement of trading of the Company's common stock on a national securities exchange; or (iv) upon a change of control of the Company, as defined in the Company's 2016 Equity Incentive Plan.